20: Psychiatric Emergencies

Published on 23/06/2015 by admin

Filed under Emergency Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1426 times

Section 20 Psychiatric Emergencies

Edited by George Jelinek

20.1 Mental state assessment

Epidemiology

Recent estimates place mental health disorders as one of the three leading causes of total burden of disease and injury in Australia, alongside cancer and cardiovascular disease.4,5,6 In middle age, it is the leading cause of non-fatal disease burden in the Australian population. There is no doubt that mental health disorders have a high prevalence, are disabling and are high cost in both human and socioeconomic terms.4,5

In terms of disability, it has been estimated that having moderate to severe depression is the equivalent of having congestive cardiac failure,6 chronic severe asthma or chronic hepatitis B.5 Severe post traumatic stress syndrome was comparable to the disability from paraplegia and severe schizophrenia was comparable to quadriplegia, in terms of disability.5 Over the last 10 years emergency department (ED) presentations have risen 8% in the USA, whereas mental health presentations for the same time period have risen 38%, contributing significantly to ED overcrowding.7 This trend has been mirrored in Australia.

Contributing to this may be:

The Australian Institute of Health and Welfare report into Mental Health Services in 2007 estimated that there were over 190 000 occasions of service to Australian EDs where the primary problem was thought to be due to a mental health disorder. This was estimated to be approximately 3.2% of total presentations to public hospital EDs.4 This correlates well with other studies and US figures, which estimate 2–6 % of emergency medicine presentations are primarily due to mental health disorders.1,7,8,9

Two-thirds of these people are between the ages of 15 and 44 years (compared to 42% for the general population presenting to a suburban ED. 29% have anxiety and neurotic disorders, 21% mental and behavioural disorders due to psychoactive substance abuse, 19% mood disorders and 17% schizophrenia or delusional disorders.7

This, of course, is a gross underestimate of the prevalence of mental health disease in the ED as many patients remain undiagnosed, and many have active medical conditions and a mental health diagnosis may be secondary.8

It is estimated that 17.7% of adult Australians admitted to hospital report a mental health issue in the previous 12 months. An estimated 0.4–0.7% of the adult population suffer from a psychotic episode in any one year.5 Mental health issues are highly prevalent and relevant.

Introduction to the mental state examination

The mainstreaming of mental health patients into general EDs has brought problems and anxieties for staff. Staff often feel a lack of confidence because they are dealing with a population of patients unfamiliar to them. They also feel inadequate due to poor assessment skills.9,10

Mental health patients are often seen as ‘low yield’, unrewarding and there is often a negative attitude expressed toward them.9,10 A high proportion have drug and alcohol intoxication. This confounds the evaluation and treatment, lengthens the stay of these patients within the ED and delays their disposition. Mental health patients are sometimes perceived as ‘frequent flyers’ – victims of chronic disease that can never be cured – and can be seen as burdensome and unrewarding.

These negative attitudes have resulted in mental health patients being assigned lower triage categories and longer waits to be seen by staff than mainstream patients. They have a higher chance of leaving before assessment has begun or is complete and the overall increase in length of assessment time has the potential to increase violence in the ED.9,10

With this in mind, there has been much work over the last 10 years on the assessment of mental health patients in a general ED.

Triage

The Mental Health Triage Scale (Table 20.1.2) has been developed and modified to be included into the Australian Triage Scale (ATS).3,9,11 It is very broad and asks the triage nurse to make four assessments: risk of suicide/self harm, risk of aggression/harm to others, risk of absconding and whether the patient is intoxicated. From this, the triage nurse determines the ATS and urgency of initial treatment. It is also helpful to determine if the patient is known to a mental health service.

Table 20.1.2 The Mental Health Triage Scale

ATS 2 Patient is violent, aggressive or suicidal, or is a danger to self or others
Requires police escort/restraint
ATS 3 Very distressed or acutely psychotic
Likely to become aggressive
May be a danger to self or others
ATS 4 Long-standing or semi-urgent mental health problem and/or has supporting agency/escort present
ATS 5 Patient has a long-standing non-acute mental health disorder but has no support agency
Many require referral to an appropriate community resource

Many centres have developed a triage risk assessment proforma. For ease of use, many of these have included ‘tick box’ areas. A compilation of multiple assessment tools used throughout Australia is shown in Tables 20.1.3, 20.1.4 and 20.1.5.1,2,3,5,11,12

Table 20.1.3 Brief screening suicide risk template

Mental state image Active disease
imageDepression
imagePsychosis
imageHopelessness/despair/guilt/shame
imageAnger/agitation
imageImpulsivity
Suicide attempts/thoughts imageContinual/specific thoughts
imageFormulated plan
imageIntent
imagePast history of attempt with high lethality
imageMeans
imageSuicide note
imageRisk of being found
imageOrganizing personal affairs
Substance abuse imageCurrent misuse
Supports imageLack of or hostile relationships
Loss imageRecent major loss (even perceived): significant relationship, job, housing, financial difficulties, independence
imageRecent/new diagnosis of major illness or chronic illness
Patients then stratified into high, medium or low risk

Table 20.1.4 Aggression risk tool

imageAlert on chart
imagePrevious history of violence/threatening behaviour: verbal or physical
imageAggressive behaviour/thoughts
imageHomicidal ideation
imageUse of weapons previously
imageAccess to weapons
imageIntoxicated
imageMiddle aged male
Patient then stratified into high, medium or low risk

Table 20.1.5 Risk of absconding

Mode of arrival
imagePolice
imageHandcuffed
imageFamily/carer coercion
imageVoluntary
imagePast history of absconding behaviour
imageAlert on chart
imageVerbalising intent to leave
imageLack of insight into illness
imagePoor/non-compliance with medication
Patients then stratified into high, medium or low risk

It is recommended that any patient who scores ‘high risk’ in any one area or ‘medium risk’ in two areas is treated as a ‘high risk’ patient. Ensuing management of ‘high risk’ patients depends on: local protocols, levels and presence of security, police intervention, restraint and sedation guidelines and guidelines for the urgent assessment by ED and/or by mental health services.

The formal psychiatric interview

Introduction

The environment in which the mental state assessment is conducted is important. Behaviourally disturbed people are unable to tolerate noise and have short concentration spans. The interview room should be quiet, private, make the patient feel safe and the interviewer should avoid all interruptions. These prerequisites are increasingly difficult to attain in current access-blocked environments.

The interviewer should sit at the same level as the patient and impart empathy. The voice should be quiet and calming. The interviewer should use non-judgemental language and open-ended questions.3,13 It is important that the interviewer also feels safe and secure. If any risk is felt, the interviewer should have security or police present in the room or just outside. Depending on state legislation and hospital policy, the interviewer may request to have the patient searched. The interviewer should also note the nearest duress alarm and/or choose to wear a personal alarm. The interviewer should sit within easy access of an exit and should never be boxed into a corner. If an interviewer begins to feel uncomfortable, there is always the option of leaving and returning to complete the assessment at a later stage. All threats, attempts and gestures suggestive of violence should be treated seriously.

Alcohol Drug use Tobacco use

The process of obtaining a mental health assessment is different to that of a general medical assessment. In a general medical history, a series of questions is asked and the response is written. In a mental health assessment, responses are also interpreted. The interviewer is asked to form an opinion as to how thoughts are processed, based on observations. The interviewer is asked to interpret the patient’s thought patterns by what and how the patient tells the interviewer.

Appearance, attitude and behaviour

This determines the patient’s ability to self care. Table 20.1.8 lists features that may require particular attention. Attitude is important as it may indicate whether a patient is compliant with management and treatment. Abnormal posturing or repetitive behaviours should be noted. These may indicate increasing thought disturbance. With increasing aggression and agitation, there may be motor restlessness, pacing and hand wringing. Tension may escalate rapidly, and steps should be taken early to diffuse the situation.

Table 20.1.8 Appearance, attitude and behaviour

General:

Cleanliness:

Eye contact:

Facial expression:

Reaction to interviewer:

Motor:

Speech:

The interviewer should note the rate, volume and rhythmicity of speech. This can range from completely mute, through monosyllabic answers, to rapid, loud speech indicative of pressure of speech. The tone, inflection content and structure of speech should also be noted. The interviewer should determine if the speech is fluent, if the thoughts behind it are logical and whether it flows appropriately for the situation.

Thought disorder

This is speech that does not reach its goal, is not fluent and is interrupted often with many pauses and/or changes in direction. A list with explanations is given in Table 20.1.9.

Table 20.1.9 Thought disorders

Circumstantiality Delays in reaching goals by long-winded explanations, but eventually gets there
Distractible speech Changes topic according to what is happening around the patient
Loosening of associations Logical thought progression does not occur and ideas shift from one subject to another with little or no association between them
Flight of ideas Fragmented, rapid thoughts that the patient cannot express fully as they are occurring at such a rapid rate
Tangentiality Responses that superficially appear appropriate, but which are completely irrelevant or oblique
Clanging Speech where words are chosen because they rhyme and do not make sense
Neologisms Creation of new words with no meaning except to the patient
Thought blocking Interruption to thought process where thoughts are absent for a few seconds and are unable to be retrieved

Conclusion

Although time-consuming and seemingly unrewarding, a good mental health assessment is vital for the appropriate management and disposition of what is an increasingly large group of patients in the ED. If able to formulate an opinion on the risk assessments regarding suicide, violence and flight risk and the aims of the MSE, the emergency medical officer will be able to present to mental health services a comprehensive picture of the patient.

Only then will the mental health professional be able to administer mental health first aid,5 the principles of which are:

References

1 Crowe M, Carlyle D. Deconstructing risk assessment and management in mental health nursing. Journal of Advanced Nursing. 2003;43(1):19-27.

2 Risk McSherryB. Assessment by Mental Health Professionals and the Prevention of Future Violent Behaviour. Australian Government. Australian Institute of Criminology, 2004. July

3 NSW Department of Health. Framework for suicide risk assessment and management. Emergency Department, 2004. http://www.health.nsw.gov.au. Online. Available

4 The Australian Institute of Health and Welfare. Mental health services in Australia 2004–5. (Mental Health Series No 9). Canberra: Australian Institute of Health and Welfare, 2007.

5 Kitchener B, Jorm A. Mental health first aid manual. Melbourne: Orygen Research Centre, 2002.

6 Clinical Practice Guidelines Team for Depression, Royal Australian and New Zealand College of Psychiatrists. Australian and New Zealand clinical practices. Practice guidelines for the treatment of depression. Australian and New Zealand Journal of Psychiatry. 2004;38:389-407.

7 Larkin GL, Classen CA, et al. Trends in US Emergency Departments. Visits for mental health conditions, 1992–2001. Psychiatric Services June. 2005;56(6):671-677.

8 ACEP Clinical Policies Subcommittee. Clinical policy: critical issues in the diagnosis and management of the adult psychiatric patient in the emergency department. Annals of Emergency Medicine. 2006;47(1):79-99.

9 Smart D, Pollard C, Walpole B. Mental health triage in emergency medicine. Australian and New Zealand Journal of Psychiatry. 1999;33:57-66.

10 Happell B, Summers M, Pinikahana J. Measuring the effectiveness of the national Mental Health Triage Scale in an emergency department. International Journal of Mental Health Nursing. 2003;12:288-292.

11 Department of Health and Ageing. Emergency triage education kit. Australian Government. 2007:37-48.

12 Department of Human Services, Victorian Emergency Department. Mental health triage tool. Online. http://www.health.vic.gov.au/emergency/mhtriagetool.pdf. Available

13 Meyers J, Stein S. The psychiatric interview in the emergency department. Emergency Medicine Clinics of North America. 2000:173-183.

20.2 Distinguishing medical from psychiatric causes of mental disorder presentations

Introduction

Emergency physicians are facing a significantly increased volume and complexity of mental disorder presentations. Increased numbers relate to increased community care for chronic mental illness, the ageing population and frequent substance abuse. Intoxicated patients, with and without mental disorder, are increasingly being presented to emergency departments (EDs) for assessment due to concerns about patient or community safety. These patients frequently display impulsive, suicidal or violent behaviour and are often difficult to manage. A thorough understanding of the assessment and appropriate disposition of mental disorder presentations is essential for all emergency physicians.

The concept of differentiating an organic from a psychiatric basis for a mental disorder is becoming increasingly blurred as research shows the biological and genetic basis of many traditional psychiatric illnesses. The accepted terminology for classification of mental disorder is also rapidly changing. One accepted Western standard is the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV).1 To emphasize the biological basis of many traditional psychiatric illnesses, DSM-IV no longer uses the term ‘organic mental disorder’. Despite this change, current clinical management and disposition still revolve around the traditional distinction of organic (medical) from psychiatric problems.

In practice emergency physicians need a simple classification defining the principal diagnosis of the presenting mental disorder consistent with current DSM-IV terminology. This should assist diagnostic, management and disposition accuracy. Table 20.2.1 is such a suggested classification. A more simplistic grouping into psychiatric, medical, substance-related or anti-social behaviour may even suffice. Correct assignment by the emergency physician to the appropriate classification, and hence appropriate disposition, reduces medical costs and morbidity.2

Table 20.2.1 A simple classification of principal diagnosis of mental disorder for emergency physicians

DSM-IV terminology Broad traditional clinical grouping Likely principal management and disposition
Axis 1
Clinical disorder due to a general medical disorder Organic Medical
Delirium, dementia and amnestic and other cognitive disorders Organic Medical
Substance-related disorder – intoxication or withdrawal disorder Organic Medical
Substance-related disorder – substance induced persistent disorder Organic Psychiatric
Clinical disorder (not identified to above or axis II principal diagnosis) Psychiatric Psychiatric

General approach

Patients with abnormal behaviour labelled as psychiatric after routine medical and psychiatric assessment frequently have a final diagnosis of a medical cause or precipitant for the mental disorder. The incidence of missed medical diagnosis ranges between 8 and 46%.24 A prospective study of ED patients in the USA showed a medical diagnosis in 63% of patients with first psychiatric presentations.5 Deciding whether a particular presentation of mental disorder is medical or psychiatric is often difficult, as there are very few absolutes that distinguish medical from psychiatric illness. Careful collection and weighing of appropriate information commonly leads to an accurate differential diagnosis.

Some diagnoses and dispositions can be determined quickly after a medical and psychiatric history, with the addition of a mental state and full physical examination. This may sometimes take place without expensive diagnostic procedures.6 Other presentations are difficult and require extensive and intensive evaluation, repeat evaluation, observation in hospital and significant investigations before the diagnosis is clear.

Many initial assessments in EDs are difficult and inaccurate owing to the presence of intoxicating substances or difficult patient factors. The latter may include poor communication ability, poor cooperation with examination, antisocial behaviour, intentional obscuring of information or denial of problems. Intoxicated patients may have other complex and distracting issues, such as threats of violence or self-harm, possible head injury, possible unknown substance overdose, and poor cooperation with necessary history, examination and investigations. A non-judgemental approach with prudent intervention based on known or likely risks, close monitoring in a safe environment, and repeated reassessment of physical and mental state over time are necessary to obtain an accurate diagnosis and optimal outcome.

Studies on medical clearance by ED staff, primary-care physicians and psychiatrists have repeatedly shown a poor ability to discover medical conditions. This failure is commonly due to one or more of the following factors: inadequate history, failure to seek alternative information from relatives, carers and old records, poor attention to physical examination, including vital signs, absence of a reasonable mental state examination, uncritical acceptance of medical clearance by receiving psychiatric staff and failure to re-evaluate over time.7 A recent study noted that medical conditions were most easily identified in the ED by the triage nurse or medical officer asking whether any medical conditions existed in addition to the patient’s psychiatric complaints.8

Conversely, studies have shown that many patients admitted with a medical diagnosis frequently have a physical presentation of a classic psychiatric disorder. In addition, patients who frequently present to EDs with physical problems commonly have abnormal illness behaviour. Inability to recognize this leads to inappropriate diagnosis and management, with subsequent treatment failure.

Psychiatric patients also have a higher incidence of physical illness than the general population. The comorbid illness may not have been diagnosed previously in this socially disadvantaged population.

Evaluation requires a thorough approach and a commitment of time and effort. Special skills are required for medical clearance and psychiatric interview. A coordinated and focused medical and psychiatric assessment has the highest yield of correct diagnoses.2 Proformas may improve compliance and documentation of important details.

Triage

Triage is vital, as many patients presenting with apparent psychiatric problems have medical conditions. The patient previously labelled psychiatric must be carefully triaged to avoid any new medical problems being overlooked. Psychiatric patients have been found to express their physical illnesses in different ways from those without mental illness. They may be suffering from severe or life-threatening illness, but fail to communicate this to their medical carers. Correct identification at the point of entry by nursing staff facilitates correct management and reduces morbidity and mortality.9 Many patients with psychiatric illness are also a significant risk to themselves or others, and require urgent intervention. Questions regarding safety should always be raised10 (Table 20.2.2).

Table 20.2.2 Triage safety questions10

Is the patient a danger to him or herself?
Is the patient at risk of leaving before assessment?
Is the patient a danger to others?
Is the area safe?

Nursing staff should use a triage checklist to identify likely organic presentations (Table 20.2.3). These are indications for urgent medical assessment. If these are absent and a psychiatric diagnosis is likely, then an appropriate urgency rating by Australasian Triage Scale for psychiatric presentations should be applied. This triage categorization for psychiatric presentations has been developed and verified, and allows reasonable waiting time standards for urgency to be applied (Table 20.2.4).11

Table 20.2.3 High-yield indicators of organic illness

Table 20.2.4 Guidelines for Australasian Triage Scale coding for psychiatric presentations11

Emergency: Category 2
Patient is violent, aggressive or suicidal, or is a danger to self or others, or requires police escort.
Urgent: Category 3
Very distressed or acutely psychotic, likely to become aggressive, may be a danger to self or others.
Experiencing a situation crisis.
Semiurgent: Category 4
Long-standing or semi-urgent mental health disorder and/or has a supporting agency/escort present (e.g. community psychiatric nurse*)
Non-urgent: Category 5
Long-standing or non-acute mental disorder or problem, but the patient has no supportive agency or escort. Many require a referral to an appropriate community resource.

* It is considered advantageous to ‘up triage’ mental health patients with carers present because carers’ assistance facilitates more rapid assessment.

Triage should consider patient privacy issues if the history obtained is to be accurate. Collateral information from the carers with the patient should always be diligently obtained, carefully considered and documented. Integration of all this information should allow the patient to be placed in an appropriate and safe environment where continuing visual and nursing observations can occur while further assessment is awaited. An emerging trend is to use nursing triage to immediately refer likely psychiatric presentations to mental health clinicians without formal ‘medical clearance’. This method appears effective and efficient for both patient and clinicians. Most triage referral systems have built-in medical safety nets and have been operating now for some years without obvious increase in adverse outcomes. They are yet to be validated by scientific studies.

History

A careful traditional medical history is the most common identifier of medical illness as a cause of a mental disorder presentation. Substance-related disorders are also most easily identified on history. A careful drug history, including prescribed, recreational and over-the-counter medications, should always be included. A slow onset and a previous psychiatric history are more commonly associated with psychiatric illness. Conversely, rapid onset, no premorbid decline and no past psychiatric history favour a medical cause. Poor recall of recent events may indicate delirium.

Family history is often a key indicator of psychiatric or medical cause. For example, a depressed 30-year-old man with a family history of Huntington’s disease or porphyria is more likely to have a physical cause. Conversely, an 18-year-old man with a hypomanic presentation and a strong family history of bipolar disorder more likely has a psychiatric cause. Suicidal and homicidal risk should be assessed routinely to ensure safety. Escalating immediate risk can often be recognized by combining patient perceived lethality and inquiry about any transition from thoughts, to actual plans and finally to actions. For patients with previous psychiatric illness the system review is a useful screen for organic illness.

HIV is an increasingly important area as HIV-related illness becomes the new great mimic of modern psychiatry and medicine. Practices likely to have put the patient at risk should be explored. These may have been in the distant past. Known positive HIV status always warrants assessment for an organic cause of any new behavioural disturbance. Clinically, these problems often initially present with symptoms of mild anxiety or depression. Many treatable medical causes are only evident after significant investigations.12

Delirium, a highly specific but not absolute indicator of medical or substance-induced disorders, should always be sought. By definition this requires a history of recent onset and of fluctuation over the course of the day. Classically there will be subtle changes in level of consciousness or the sleep–wake cycle. Patients may not be able to attend sufficiently to give this history if delirious. The psychiatric history, including life profile, may give evidence of the presence or absence of premorbid decline. An abrupt onset of abnormal behaviour with no premorbid decline is more suggestive of an organic cause.

Examination

Lack of attention to important details of the examination is a frequently identified cause of missed medical illness. Areas that commonly yield positive findings, but which are frequently omitted, are the neurological examination, a search for general or specific appearances of endocrine disease, the toxidromes, examination for signs of malignancy, drugs or alcohol abuse, and vital sign examination.

Mental state examination

This is an account of objective findings of mental state signs made at the time of interview. It is the psychiatric equivalent of the medical examination, and specifically details the current status.13 Observations made by other staff in the department, such as hallucinations, may be very significant and can be included with the source identified. Careful consideration of the mental status frequently clearly distinguishes medical from psychiatric illness, and guides further investigation and management. For example, the presence of delirium or other significant cognitive defects make an organic illness almost certain. Delirium can be very subtle. Sometimes, owing to the fluctuating nature, the patient may appear normal on a single interview. Other less obvious features, such as lability of mood, variability of motor activity or lapses in patient concentration making the interview more difficult, can be the only clues and can be easily overlooked. The importance of formulation using collateral history and repeated mental state examination is stressed. Documentation is important so that mental status changes with time during assessment can be appreciated.

Examination tools

Cognitive defects may be rapidly and reliably identified in the ED during mental status examination by the use of Folstein’s Mini Mental State Examination (MMSE)14 (Table 20.2.5). A score of less than 20 suggests an organic aetiology. A fall of two or more points on serial MMSE is highly suggestive of delirium.15 Elderly patients with delirium or cognitive defects are frequently not recognized by emergency physicians.16 These patients are at high risk of morbidity and mortality.17 Simple assessment methods such as the confusion assessment method (CAM) are rapid, reliable methods of identifying delirium in older patients, suitable for ED use.18 Use of such simple methods should be encouraged to reduce inappropriate disposition. The tests above are suitable screening tools for EDs but are not intended to replace formal neuropsychological assessment. Proformas of medical history, mental state examination and physical examination may improve thoroughness of assessment and documentation.

Table 20.2.5 Mini-mental state examination14,15

Date of assessment Cognition Points
Orientation
1. What is the date? 1
What is the day? 1
What is the month? 1
What is the year? 1
What is the season? 1
2. What is the name of this building? 1
What floor of the building are we on? 1
What city are we in? 1
What state are we in? 1
What country are we in? 1
Registration
3. I am going to name three objects. After I have said them I want you to repeat them. Remember what they are because I am going to ask you to name them in a few minutes.
APPLE TABLE PENNY
  APPLE 1
  TABLE 1
  PENNY 1
Code first attempt and then repeat the answers until the patient learns all three.
Attention and calculation
4. Can you subtract 7 from 100, and then subtract 7 from the answer you get and keep subtracting until I tell you to stop? 93 1
86 1
79 1
72 1
65 1
OR
5. I am going to spell a word forwards and I want you to spell it backwards. The word is ‘WORLD’.
Now you spell it backwards. Repeat if necessary.
  D 1
  L 1
  R 1
  O 1
  W 1
Recall
6. Now what are the three objects I asked you to remember?
  APPLE 1
  TABLE 1
  PENNY 1
Language
7. Show wristwatch
What is it called?
Interviewer: Show pencil
What is it called? 2
8. I’d like you to repeat a phrase after me.
‘NO IFS ANDS OR BUTS’ 1
9. Read the words on the bottom of this table and do what it says. 1
10. Interviewer: Read the full statement below before handing the respondent a piece of paper. ‘Do not repeat or coach.’
I am going to give you a piece of paper.
What I want you to do is take the paper in your right hand, fold it in half and put the paper on your lap. Takes with right hand 1
  Folds in half 1
  Puts on lap 1
11. Write a complete sentence on this piece of paper. Sentence should have subject, verb and make sense. Spelling and grammatical errors are okay. 1
12. Here is a drawing. Please copy the drawing on the same paper. Hand drawing to respondent. Correct if two convex five-sided figures and intersection makes a four-sided figure. 1
TOTAL SCORE………………………………………………………………………………………………………
(Score best of question 4 or 5 to give a total out of 30)
A score of 20 or less indicates cognitive impairment.
CLOSE YOUR EYES

Diagnostic formulation

Emergency physicians should suspect organic disease until proved otherwise. In particular, reversible medical causes of abnormal mental state should be sought. Proformas improve documentation and summation.22 Consideration of the factors in Table 20.2.6 may help to determine doubtful cases. There are few absolutes that distinguish organic from psychiatric patients. Use of the five-axis DSM-IV system improves the ability to look at the patient’s presentation in the context of total functioning.1 It also allows emergency physicians to communicate with psychiatric peers in the recognized language.

Table 20.2.6 Factors influencing the likelihood of medical or psychiatric illness as the principal diagnosis

Organic Psychiatric
Abnormal vital signs Family history of psychiatry disorder
Age >40 with first psychosis Past psychiatric illness
Delirium Fully orientated
Conscious level fluctuates Clear sensorium
Inability to attend
Memory impaired
Impaired cognitive abilities Intact cognition
Neurological signs, e.g. dysarthria
Abnormal physical signs
Abrupt onset Slow onset
Dramatic change in general status (hours to days) Premorbid slow deterioration in employment/family/socially
Recent medical problem Recent significant life event
Medication, drugs/alcohol/withdrawal Non-compliance psychiatric medication
Marked new personality changes

Disorganized delusions Structured delusions Movement disorders Somatic passivity experiences. Perseveration Confabulation Illusions or misinterpretations Circumstantiality Concretism Thought withdrawal, insertion or broadcasting FH degenerative brain disease FH heritable metabolic

FH, family history.

Some patients require periods of observation, re-examination and further investigations before a definitive answer is obtained. Intoxicated patients frequently are not assessable till sober. Interim care and disposition varies depending on presentation, prior history and facilities available.

A common expectation of emergency physicians for patients referred to psychiatrists is to document that the patient is ‘medically cleared’. The assessment is known to be imprecise and difficult.25,810,22 Better documentation is to state that the ED assessment has revealed no evidence of an emergent medical problem.

Conclusion

A thorough medical history, psychiatric history, collateral history, physical examination, mental state examination and judicious specific investigation will identify most patients likely to have an underlying physical cause for a mental disorder presentation. Omission of any of these steps may lead to missed medical diagnosis and incorrect disposition.

Controversies and future directions

References

1 American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.

2 Hoffman RS. Diagnostic errors in the evaluation of behavioural disorders. Journal of the American Medical Association. 1982;248:964-967.

3 Koranyi EK. Morbidity and rate of undiagnosed physical illnesses in a psychiatric clinic population. Archives of General Psychiatry. 1979;36:414-419.

4 Hall RC, Popkin MK, Devaul RA, et al. Physical illness presenting as psychiatric disease. Archives of General Psychiatry. 1978;35:1315-1320.

5 Henneman PL, Mendoza R, Lewis RJ. Prospective evaluation of emergency department medical clearance. Annals of Emergency Medicine. 1994;24:672-677.

6 Allen MH, Faumann MA, Morin FX. Emergency psychiatric evaluation of ‘organic’ mental disorders. New Directions for Mental Health Services. 1995;67:45-55.

7 Tintinalli JE, Peacock FW, Wright MA. Emergency medical evaluation of psychiatric patients. Annals of Emergency Medicine. 1994;23:859-862.

8 Olshaker JS, Browne B, Jerrard DA, et al. Medical clearance and screening of psychiatric patients in the emergency department. Academic Emergency Medicine. 1997;4:124-128.

9 Ferrera PC, Chan L. Initial management of the patient with altered mental status. American Family Physician. 1997;55:1773-1780.

10 Pollard C. Psychiatry reference book – nursing staff. Hobart: Department of Emergency Medicine Royal Hobart Hospital, 1994.

11 Smart D, Pollard C, Walpole B. Mental health triage in emergency medicine. Australian and New Zealand Journal of Psychiatry. 1999;33:57-66.

12 Sternberg DE. Testing for physical illness in psychiatric patients. Journal of Clinical Psychiatry. 1986;47(suppl 1):3-9.

13 Dakis J, Singh B. Making sense of the psychiatric patient. Foundations of clinical psychiatry. Melbourne: Melbourne University Press, 1994;79.

14 Folstein MF, Folstein SE, McHugh PR. ‘Mini Mental State’: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 1975;12:189-198.

15 O’Keefe ST, Mulkerrin EC, Nayeem K, et al. Use of serial Mini-Mental State Examinations to diagnose and monitor delirium in elderly hospital patients. Journal of American Geriatrics Society. 2005;53(5):867-870.

16 Hustey FM, Meldon SW. The prevalence and documentation of impaired mental status in elderly emergency department patients. Annals of Emergency Medicine. 2002;39(3):248-253.

17 Trzepacz P, McIntyre SC, Charles, et al. Practice guideline for the treatment of patients with delirium. American Journal of Psychiatry. 1999;156(5 suppl):1-20.

18 Inouye SK, van Dyck CH, Alessi CA, et al. Clarifying confusion. The confusion assessment method. A new method for detection of delirium. Annals of Internal Medicine. 1990;113:941-948.

19 Weinberger DR. Brain disease and psychiatric illness: when should a psychiatrist order a CAT scan? American Journal of Psychiatry. 1984;41:1521-1527.

20 Sata LS. Diagnosing organic psychosis. Maryland State Medical Journal. 1970;19(2):61-64.

21 Ananth J, Gamal R, Miller M, et al. Is routine CT head scan justified for psychiatric patients? A prospective study. Journal of Psychiatry and Neuroscience. 1993;18:69-73.

22 Riba M, Mahlon H. Medical clearance: fact or fiction in the hospital emergency room. Psychosomatics. 1990;31:400-404.

20.3 Deliberate self-harm/suicide

Essentials

Introduction

Suicide is a deliberate act of intentional self-inflicted death. It is the most extreme expression of suicidality, which also comprises suicidal thoughts, threats, planning and attempted suicide through deliberate self-harm (DSH). Although suicide is uncommon, 10% of people who commit suicide are seen in an emergency department (ED) in the month prior to death, with a substantial proportion not having psychosocial assessment, thus providing an opportunity for intervention.1,2 The major ED impact, however, is in the assessment of large numbers of potentially suicidal patients, accurate risk stratification, and initial control and management of these patients.

DSH is a maladaptive response to stress and a manifestation of suicidality, but can also occur without any intent to die with other psychiatric and personality disorders.3 Deliberate self-harm is a common ED presentation (approximately 0.5% of all ED visits4) and the goals of management include treatment of the physical sequelae, assessment of risk of non-fatal or fatal repetition, and diagnosing and commencing treatment of potentially reversible psycho-social causes.5

Incidence

In Australia there were approx 2100 deaths per year from suicide in 2004 and 2005, with age-standardized rates of approximately 16.4 per 100 000 in males and 4.3 in females.6 Suicide accounts for 1.6% of deaths in Australia and is in the top 10 causes of death despite a reduction of approximately 30% in suicide rates from 1997 to 2004.7 Suicide rates are similar in the UK, New Zealand, Canada and the USA, suicide accounting for 1–2% of all deaths in these countries.6,811 The national rates of suicide vary: Japan, Scandinavian and Eastern European countries have population suicide rates as high as 25:100 000, whereas some southern European and Middle Eastern countries have rates less than 5:100 000.11,12

Hospital presentations for DSH are at least 10 times higher than suicide rates.6,9 In the 1997 Australian National Survey of Mental Health, 0.3% of males and 0.4% of females reported they had made a suicide attempt in the previous 12 months. Most of these are not reported or are reported as accidents. Hence unrecognized DSH is at least as frequent as that recognized. The same survey reported 2.7% of males and 4.5% of females experienced suicidal thoughts within 12 months.13 This rate may be as high as 25% in certain populations and age groups.14,15

Aetiology

No specific psychological or personality structure is associated with suicide, and patients who commit suicide or DSH do so for many unrelated reasons. The precipitant may be a personal crisis or life change amplified by poor social support, substance abuse or psychiatric disorder. Intoxication may decrease inhibitions enough to allow an act to proceed.

The most frequent methods of suicide in Australia are hanging (approximately 50% of male and 40% of female suicide deaths) and deliberate self-poisoning (approximately 30% of males and 40% of females). Firearms accounted for 7% of suicide deaths in Australia in 2005, a rate which has declined from 20% a decade prior, possibly due to firearm restriction legislation.6 Proportions due to each method vary according to region, residence, age and sex.1,16 In the USA, firearms accounted for 57% of male and 32% of female suicide deaths. In many developing countries, organophosphate or antimalarial poisoning is the most common method of suicide.17,18

One-third of patients with DSH express a wish to die, but most seek attention or want to communicate distress. Other reasons include release of tension, escape from a stressful situation, blotting out distressing thoughts, eliciting guilt, manipulating others, expressing anger or grief, or escaping from custody. Many patients threaten suicide or exaggerate suicidality to increase the likelihood of admission to hospital. These patients are more likely to be substance dependent, antisocial, homeless, unmarried and in legal difficulty. However, these instances of secondary gain should not be assumed to be the cause of the suicidality and the behaviour should be taken seriously.

Most cases of medically serious DSH are due to self-poisoning, with 90% associated with alcohol intoxication. The most common drugs are non-prescription analgesics and psychotropic drugs. Many overdoses are related to recreational drug use and may be accidental rather than deliberate, although this distinction is often difficult. Self-injury usually involves cutting of the wrist or forearm. Some people self-inflict cigarette burns, excoriate their skin or hit themselves. More violent forms of self-injury are less common and suggest serious suicidal intent. Bizarre self-mutilation may occur in psychotic patients who may not necessarily have an intention to die. Self-immolation, suicide bombing and hunger striking as forms of protest are special concerns.

Patient characteristics

Demographic factors

Social and cultural factors

Suicide rates are higher in those who live alone or are in a lower social group, especially in urban areas characterized by social deprivation and overcrowding. Marriage reinforced by children decreases the risk of suicidal behaviour. Being single, separated, divorced or widowed increases the risk of suicide two- to threefold.

Recent data in Australian Aboriginal people report substantially higher suicide rates that commence at a lower age than in the non-Aboriginal population.6,19 This has also been reported in New Zealand Maoris, Native Americans and Inuit in Canada.9,10,21 Suicide rates of migrants initially reflect rates in the country of origin and converge toward the Australian rate over time.

Some higher social status groups such as doctors, dentists, musicians, lawyers and law-enforcement officers are more prone to suicide.22 Most adults (75%) with DSH have relationship problems with their partners, and teenagers with their parents. A major argument or separation often precedes the act on a background of ongoing social difficulties and substance use.

Psychiatric factors

There is a pre-existing psychiatric disorder in 90–100% of cases of suicide, of which depression accounts for 66–80%, but this rate may be based on retrospective psychological analysis.23,24 The rate of suicide among psychiatric inpatients is 3–12 times higher than in the general population and involves more violent methods, such as jumping from buildings, hanging or jumping in front of vehicles. One-third of these episodes occur after self-discharge from hospital, with another third occurring during approved leave. The high-risk time is the first week of admission and during the first 3 months after discharge.25 Psychiatric disorders are present in up to 60% of patients who commit DSH, but may be transient and secondary to acute psycho-social difficulties.

Affective disorders

The psychiatric diagnosis that carries the greatest risk of suicide is mood disorder, particularly major depression if associated with borderline personality disorder, anxiety or agitation.26 Fifteen per cent of these high-risk patients commit suicide over a lifetime. Depression correlates well with the occurrence of suicidal desire and ideation, but may not be as strong a predictor of planning and preparation (intense thoughts, plans, courage and capability) and, therefore, suicide completion.24 Hopelessness is the most important factor associated with suicide completion and may be of greater importance than suicidal ideation or depression itself.24 Depressed patients should, therefore, have their attitudes towards the future carefully assessed.

Substance abuse

Fifteen per cent of alcohol-dependent persons eventually commit suicide. The majority of these are also depressed. The risk is higher if associated with social isolation, poor physical health, unemployment and previous suicidal behaviour. The increased risk may be more pronounced in males aged below 35 years.27 There is an increased risk of suicide in patients who use recreational drugs. Young male heroin addicts may have 20 times the risk of the general population. Chronic alcohol dependence is uncommon in DSH, but alcohol intoxication is involved in 50–90% of suicide attempts.

Assessment

A person who expresses suicidal ideation or commits an act of DSH is sending a distress signal that emergency physicians must recognize and assess for further risk. Suicidality should also be assessed in patients with symptoms or signs of depression, unusual behavioural changes, substance abuse, psychiatric disorders, complainants of sexual violence,28 and those who present with injuries of questionable or inconsistent mechanism, such as self-inflicted lacerations and gunshot wounds or motor vehicle accidents involving one victim.

Assessment requires a systematic, multidisciplinary approach involving prior staff education, appropriate triage, observation and restraint procedures, and a planned strategy for assessment followed by treatment and disposition. The priorities are to define the physical sequelae of the act, risk of further suicidal behaviour, psychiatric diagnoses and acute psycho-social stressors. These aspects are those that can then be targeted for short-term interventions.

Triage

In a patient who has attempted DSH, initial management involves resuscitation, treatment of immediate life threats and preventing complications. The patient should be triaged according to the physical problem as well as current suicidality, aggressiveness and mental state. The mental health triage scale can be used for this purpose.29 A triage score of 2 or 3 should be applied if patients are violent to themselves or others, actively suicidal, psychotic or distressed, or at risk of leaving before full assessment. Constant observation is required at this point and nursing staff, orderlies, security or police may be needed.

Suicide risk assessment

Initially, this needs to be done in the ED so as to determine patient disposition, but full psychiatric assessment may need to wait until drug effects wear off. Other sources of information need to be accessed since patient history can be unreliable or incomplete. Friends, family, local doctor, ambulance officers, helping agencies already involved and previous presentations documented in the medical record can all add useful information in order to complete an assessment. A therapeutic relationship should be formed and the clinician should be non-judgemental, non-threatening and clearly willing to help. A negative attitude is common among emergency personnel, especially with repeat attenders. This may intensify the patient’s already low self-esteem, increasing future suicide potential and making a therapeutic relationship difficult to establish.30 When managing a patient who may be suicidal, the suicidal ideation should be discussed openly. This does not increase the likelihood of attempted suicide and may make the patient realize there are other options.

Assessment of suicide risk involves assessing background demographic, psychiatric, medical and social factors, as well as the current circumstances and suicidal behaviour itself, as outlined in Table 20.3.1. There are epidemiological differences between people who attempt suicide and those who complete suicide. Although the groups are different, there is an important overlap. The more an individual’s characteristics resemble the profile of a suicide completer, the higher the risk of future suicide or suicide attempts. Despite this, in long-term follow-up studies very few of these factors have been shown to be good independent predictors of suicide following DSH. The most consistent factors are psychiatric illness, personality disorder, substance abuse, multiple previous attempts, and current suicidality and hopelessness. Guidelines are available to assist in suicide-risk stratification and describe characteristics associated with suicide-risk levels and the appropriate further assessment and disposition for each group.31

Table 20.3.1 Factors associated with suicide30

Variable High risk Low risk
Background factors
Gender Male Female
Marital status Separated, divorced, widowed Married
Employment Unemployed or retired Employed
Medical factors Chronic illness, chronic pain, epilepsy Good health
Psychiatric factors Depression, bipolar, schizophrenia, panic disorder, previous psychiatric inpatient, substance abuse No psychiatric history, normally robust personality
Social background Unresponsive family, socially isolated or chaotic, indigenous background Supportive family, socially stable and integrated
Current factors
Suicidal ideation Frequent, prolonged, pervasive Infrequent, transient
Attempts Multiple First attempt
Lethality Violent, lethal and available method, aware of medical dangerousness Low lethality, poor availability
Planning Planned, active preparation, extensive premeditation Impulsive, no realistic plan, telling others prior to act
Rescue Act performed in isolation, event timed to avoid intervention, precautions taken to avoid discovery Rescue inevitable, obtained help afterwards
Final acts Wills, insurance, giving away property  
Coping skills Unwilling to seek help, feels unable to cope with present difficulties Can easily turn to others for help, can plan to overcome present difficulties, willing to become involved in aftercare
Current ideation Admitting act was intended to cause death, no remorse, continued wish to die, hopelessness or helplessness Primary wish to change, pleased to recover, suicidal ideation resolved by act, optimism
Precipitant Similar circumstances can recur, acute precipitant not resolved Stressful but transient life event, acute precipitant addressed

Use of scales

Many screens have been devised to identify high-risk groups within those presenting with DSH. PATHOS,32 the Suicidal Intent Scale,33 the Sad Persons Scale34 and other scoring systems have been devised to complement medical assessment of suicide risk. The modified Sad Persons Scale (Table 20.3.2) incorporates some high-risk characteristics to predict suicide risk in patients with suicidal ideation or behaviour. However, many of these scales use outdated risk factors and patient populations unrepresentative of EDs. Scales need to be sensitive, but this misclassifies a large number of individuals as potentially suicidal. These deficiencies need to be considered when applying suicide risk scales in the ED and these scales should not be used as an absolute assessment of suicide risk or of the need for psychiatric admission.35,36 The problems associated with suicide-risk assessment are summarized in Table 20.3.3.

Table 20.3.2 Modified Sad Persons Scale34

Variable Score
Gender: male 1
Age: <19 or >45 years 1
Depression: hopelessness, despair, especially if associated with physiological shift symptoms 2
Psychiatric care: previous DSH, psychiatric care or severe personality disorder 1
Excessive drug use 1
Rational thinking loss: severe depression with psychotic features, organic brain syndrome, delusions 2
Single, separated, divorced, widowed 1
Organized attempt: planned, premeditated, lethal and available method 2
No life supports: social isolation, homeless, unemployed 1
States future intent: continued suicidal ideation 2

Table 20.3.3 Problems in assessing suicide risk

Suicide is rare, even in high-risk groups, so it cannot be predicted without a high rate of false-negative or false-positive errors
Suicidality presents in heterogeneous ways that may not be recognized
Suicidality is transient and affected by intoxication, stress and being in hospital
The patient may be reluctant, oppositional or manipulative
The patient may present in an atypical fashion, especially the elderly with physical complaints
Suicide risk factors identify high-risk subgroups but not individuals
The demographic factors associated with suicide have changed recently, thus changing the make-up of risk groups
Risk factors are based on studies of long-term follow-up and, therefore, long-term risk
Subtle changes in mental status and behaviour may be missed if not assessed by the usual doctor
Unexplained improvement in psychological status may be the result of increased motivation to die
Patients may deny their true intentions due to embarrassment, fear of being stopped in carrying out their own wishes, fear of being institutionalized or fear of the confidentiality of the interview
Patients may say life is not worth living or that they feel they would be better off dead, but not necessarily have an increased risk of suicide, unless they have made suicidal plans or attempts, or if they have pervasive hopelessness
Correlation between medical danger and suicidal intent is low unless the patient can accurately assess the probable outcome of their attempts if treatment had not been received

Definitive treatment and disposition

Following necessary medical treatment and suicide-risk stratification, disposition may involve involuntary or voluntary admission to a psychiatric or medical ward, short-term or overnight observation, or discharge with appropriate follow-up. Restraint and involuntary admission may be necessary for the high-risk patient who wishes to self-discharge. Approximately 30% of DSH patients are admitted for psychiatric inpatient care but the factors involved in the decision for psychiatric hospitalization following DSH are not well understood and involve a complex evaluation of risk, potential for treatment and social supports.37

Overnight observation allows drug intoxication to resolve so that proper psychiatric assessment can take place. An overnight stay in hospital can also help resolution of many acute areas of conflict and make psychiatric evaluation more accurate. ED short-stay wards are appropriate for these admissions, especially if a multi-disciplinary team is available to review the patient and institute management and follow-up.

Important elements of management involve neutralizing the precipitating problem, treatment of psychiatric illness and environmental interventions such as family counselling, encouraging a support network, and developing coping and problem-solving skills.38 Open discussion about suicide should be undertaken and a firm stance should be maintained that suicide is an ineffective solution. Alternative, non-suicide solutions should be reinforced. Other factors that should be addressed whilst patients are in hospital include problems with relationships, employment, finances, housing, legal problems, social isolation, alcohol and drug abuse, and bereavement. In this regard, medical social workers or mental health nurses are invaluable.39 For greatest effect, these should be available after hours and on weekends since the majority of DSH presents after hours.40 For repeat attenders or manipulative patients who are often socially isolated, hospitalization should not be a substitute for social services, substance-abuse treatment and legal assistance, although admission may be necessary while appropriate supports are put in place.41

Discharge is appropriate for the low-risk patient who is cooperative, no longer suicidal, not intoxicated, has no underlying psychiatric or substance abuse disorder, and has strong social support with the precipitating problem having resolved due to the act or subsequent assessment and intervention in hospital. Discharged patients should make a commitment to seek help if they reach a crisis point, and the physician should be available to help. This can be part of a commitment to a non-suicidal behavioural plan between the patient and clinician. This contract should be with the clinician who will arrange definitive care. Contracts may delay the patient’s suicidal impulses so that other treatment strategies can be implemented. If discharged, there should be liaison with the patient’s general practitioner and therapist, and follow-up should be confirmed where possible within 1–2 days.

Pharmacotherapy involves the treatment of the underlying psychiatric disorder. Antidepressants decrease the risk of attempting suicide, although the lethality of suicide attempts is increased if tricyclic antidepressants are taken in overdose. Selective serotonin reuptake inhibitors may have a more selective effect in decreasing suicidal behaviour and are less toxic in overdose. These factors make this class of drugs an attractive choice for depressed patients who are suicidal, but any long-term therapeutic drug should, ideally, be prescribed by the doctor who will provide definitive follow-up.42

Consequences

Risk of suicide

An episode of DSH is probably the best predictor of future suicide. Approximately 1–2% of patients commit suicide during the year following an attempt and in approximately 40% of suicides there is a history of a previous attempt. A systematic review of fatal and non-fatal repetition of self-harm reported a suicide rate of 2% at 1 year and 7% after 9 years.43 In a prospective Finnish 14-year follow-up study, and a UK 18-year follow-up study, the rate of suicide after an episode of DSH was 6.7%.44,45 A 10-year follow-up study in New Zealand documented a suicide rate of 4.6% in patients admitted for DSH.46 Hospitalization and aftercare decrease short-term risk of suicide, but have little impact on long-term risk of suicide. However, this may be due to under-treatment of psychiatric illness.23,47,48

Exposure to suicide in adolescents tends not to cause an increased risk of suicide among friends but may cause an increased incidence of depression anxiety, and post-traumatic stress disorder.49

Repeated episodes of DSH

DSH usually invokes help from friends, family and the medical profession so that the patient’s social situation and psychological wellbeing tends to improve.50 This cathartic effect is prominent in younger patients but may not occur in patients aged over 60 years.51 The risk of repetition is 12–16% in the following year, with 10% of these occurring in the first week.43,49 This is more likely in females who are unemployed, have cluster B personality traits or have substance-abuse problems.

Patients with DSH who leave the ED prior to a psychosocial assessment may have a higher risk for repeat DSH, probably associated with lack of specialist follow-up and treatment of reversible factors.52,53

Some patients have chronic suicidal ideation and multiple repetitions of DSH. They often suffer from personality disorders, psychotic disorders, chronic medical conditions, alcohol or drug use, a history of childhood sexual abuse54,55 and violent behaviour. They use DSH as a means of fighting off anxiety, hopelessness, loneliness or boredom, or for manipulation of family, friends or health carers. These patients place a heavy burden on hospital resources, are difficult to treat and have a high rate of eventual suicide. Reversible potentiating factors should be addressed where possible.

Increased all cause mortality

A suicide attempt is associated with a severe risk of premature death with the increased mortality rate not entirely due to suicide.56 There is a higher than expected rate of accidents, homicides and death from other medical conditions. This may indicate social disadvantage, a disengagement with the health system, underlying chronic illnesses or lifestyle factors.

Prevention

Comprehensive strategies for prevention of suicide have been or are being developed in Finland, Norway, Sweden, Australia and New Zealand.12 Suicide prevention focuses on psychiatric, social and medical aspects, and usually involves public education, media restrictions on reporting of suicide, school-based programmes with teacher education, training of doctors in detection and treatment of depression and other psychiatric disorders, alcohol and drug-abuse information, enhanced access to the mental health system and supportive counselling after episodes of DSH. Decreasing the availability of lethal methods may involve legislative changes such as more stringent gun control, restricting access to well-known jumping sites or changes to availability or packaging of tablets.57 Overall, studies into the effectiveness of suicide-prevention strategies have shown inconsistent reductions in suicide rates following interventions.58 Approaches to reduce DSH repetition have also shown disappointing results.59 Improved recognition and treatment of mental illness, improved social services, and drug- and alcohol-support services may be of greater benefit than specific suicide-prevention strategies.

Conclusion

Assessment of suicide risk is an important skill in emergency medicine since many patients present to EDs with suicidal thinking or behaviour. Although the risk of suicide for an individual patient is remote and cannot be predicted, emergency physicians can provide a system for assessment and identification of risk groups. Acute interventions can attempt to prevent short-term completion of suicide or repetition of DSH, since emergency physicians are predominantly involved in the care of these patients, often using short-stay wards. A team approach involving psychiatry and social work is necessary in most cases, with many minor problems resolved by a short-term hospital admission, brief crisis intervention and intense short-term follow-up.

References

1 Salter A, Pielage P. Emergency departments have a role in the prevention of suicide. Emergency Medicine. 2000;12:198-203.

2 Gairin I, House A, Owens D. Attendance at the accident and emergency department in the year before suicide: retrospective study. British Journal of Psychiatry. 2003;183:28-33.

3 Mitchell AJ, Dennis M. Self harm and attempted suicide in adults: 10 practical questions and answers for emergency department staff. Emergency Medicine Journal. 2006;23:251-255.

4 Doshi A, Boudreaux ED, Wand N, et al. National study of US emergency department visits for attempted suicide and self-inflicted injury, 1997–2001. Annals of Emergency Medicine. 2005;46:369-375.

5 Boyce P, Carter G, Penrose-Wall J, et al. Summary Australian and New Zealand clinical practice guideline for the management of adult deliberate self-harm. Australasian Psychiatry. 2003;11:150-155.

6 Australian Bureau of Statistics. 3309.0 Suicides, Australia [Internet homepage]. 2005. http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/3309.0Main+Features12005?. [updated 2007, Mar 14; cited 2007, Nov 22]. Available:

7 Australian Bureau of Statistics. 3303.0 Causes of Death, Australia [Internet homepage]. 2005. http://www.abs.gov.au/AUSSTATS/abs@.nsf/mf/3303.0/. [updated 2007, Apr 16; cited 2007, Nov 22]. Available:

8 Office for National Statistics. Death rates from suicide [Internet homepage]. 2007. http://www.statistics.gov.uk/statbase/Product.asp?vlnk=13618. [updated 2007, Feb 22; cited 2007, Nov 22]. Available:

9 New Zealand Health Information Service. Suicide facts: provisional 2003 all-ages statistics [Internet homepage]. 2003. http://www.nzhis.govt.nz/stats/suicidefacts2003.pdf. [updated 2006, Feb; cited 2007, Nov 22]. Available:

10 American Association of Suicidology. USA Suicide: 2004 official final data [Internet homepage]. 2004. http://www.suicidology.org/associations/1045/files/2004datapgu1.pdf. [updated 2006, Dec 15; cited 2007, Nov 22]. Available:

11 World Health Organisation. Suicide rates [Internet homepage]. 2003. http://www.who.int/mental_health/prevention/suicide/suiciderates/en/. [updated 2003, May; cited 2007, Nov 22].Available:

12 Taylor SJ, Kingdom D, Jenkins R. How are nations trying to prevent suicide? An analysis of national suicide prevention strategies. Acta Psychiatrica Scandinavia. 1997;95:457-463.

13 Pirkis J, Burgess P, Dunt D. Suicidal ideation and suicide attempts among Australian adults. Crisis. 2000;21:16-25.

14 McKelvey RS, Pfaff JJ, Acres JG. The relationship between chief complaints, psychological distress, and suicidal ideation in 15–24 year-old patients presenting to general practitioners. Medical Journal of Australia. 2001;175:550-552.

15 Bertolote JM, Fleischmann A, De Leo D, et al. Suicide attempts, plans, and ideation in culturally diverse sites: the WHO SUPRE–MISS community survey. Psychological Medicine. 2005;35:1457-1465.

16 Dudley MJ, Kelk NJ, Florio TM. Suicide among young Australians, 1964–1993: an interstate comparison of metropolitan and rural trends. Medical Journal of Australia. 1998;169:77-80.

17 Arun M, Menezes RG, Babu YPR. Autopsy study of fatal deliberate self harm. Medicine, Science & the Law. 2007;47:69-73.

18 Eddleston M. Patterns and problems of deliberate self-poisoning in the developing world. Quarterly Journal of Medicine. 2000;93:715-731.

19 Baume P. Suicide in Australia: do we really have a problem? Australian Journal of Education & Developmental Psychology. 1996;13:3-39.

20 Hawton K, Harriss L. Deliberate self-harm in people aged 60 years and over: characteristics and outcome of a 20-year cohort. International Journal of Geriatric Psychiatry. 2006;21:572-581.

21 Isaacs S, Keogh S, Menard C, et al. Suicide in the Northwest Territories: a descriptive review. Chronic Diseases in Canada. 2000;19. http://www.phac-aspc.gc.ca/publicat/cdic-mcc/19-4/c_e.html. [serial online]. [cited 2007, Nov 22]. Available:

.

22 Kaplan HI, Sadock BJ, Grebb JA. Kaplan and Sadock’s synopsis of psychiatry, 7th edn, Baltimore: Williams & Wilkins; 1994:803-809.

23 Lönnqvist JK, Henriksson MM, Isometsä ET, et al. Mental disorders and suicide prevention. Psychiatry and Clinical Neurosciences. 1995;49:S111-S116.

24 Hawton K. Assessment of suicide risk. British Journal of Psychiatry. 1987;150:145-153.

25 Shah AK, Ganesvaran T. Inpatient suicides in an Australian mental hospital. Australia and New Zealand Journal of Psychiatry. 1997;31:291-298.

26 Gilbody S, House A, Owens D. The early repetition of deliberate self harm. Journal of Royal College Physicians London. 1997;31:171-172.

27 Cooper J, Kapur N, Webb R, et al. Suicide after deliberate self-harm: a 4-year cohort study. American Journal of Psychiatry. 2005;162:297-303.

28 Campbell L, Keegan A, Cybulska B. Prevalence of mental health problems and deliberate self-harm in complainants of sexual violence. Journal of Forensic Legal Medicine. 2007;14:75-78.

29 Smart D, Pollard C, Walpole B. Mental health triage in emergency medicine. Australian and New Zealand Journal of Psychiatry. 1999;33:57-66.

30 Rund DA, Hutzler JC. Behavioral disorders: emergency assessment and stabilization. In: Tintinalli JE, Kelen GD, Stapczynski JS, editors. Emergency medicine: a comprehensive study guide. 6th edn. New York: American College of Emergency Physicians, McGraw-Hill; 2004:1812-1816.

31 Australasian College for Emergency Medicine and the Royal Australian and New Zealand College of Psychiatrists. Guidelines for the management of deliberate self harm in young people. Victoria: ACEM and RANZCP, 2000.

32 Kingsbury S. PATHOS: a screening instrument for adolescent overdose: a research note. Journal of Child Psychology and Psychiatry and Allied Disciplines. 1996;37(5):609-611.

33 Beck AT, Schuyler D, Herman J. Development of suicidal intent scales. In: Beck AT, Resruk HLP, Lettieri DJ, editors. The prediction of suicide. Maryland: Charles Press, 1974.

34 Hockberger RS, Rothstein RJ. Assessment of suicide potential by nonpsychiatrists using the SAD PERSONS score. Journal of Emergency Medicine. 1988;6:99-107.

35 Cochrane-Brink KA, Lofchy JS, Sakinofsky I. Clinical rating scales in suicide risk assessment. General Hospital Psychiatry. 2000;22:445-451.

36 Harriss L, Hawton K. Suicidal intent in deliberate self-harm and the risk of suicide: the predictive power of the Suicide Intent Scale. Journal of Affective Disorders. 2005;86:225-233.

37 Carter GL, Safranko I, Lewin TJ, et al. Psychiatric hospitalisation after deliberate self-poisoning. Suicide and Life-Threatening Behavior. 2006;36(2):213-222.

38 Brent DA. The aftercare of adolescents with deliberate self harm. Journal of Child Psychology and Psychiatry and Allied Disciplines. 1997;38(3):277-286.

39 Brakoulis V, Ryan C, Byth K. Patients seen with deliberate self-harm seen by a consultation–liaison service. Australasian Psychiatry. 2006;14:192-197.

40 Bergen H, Hawton K. Variations in time of hospital presentation for deliberate self-harm and their implications for clinical services. Journal of Affective Disorders. 2007;98(3):227-237.

41 Lambert MT, Bonner J. Characteristics and six-month outcome of patients who use suicide threats to seek hospital admission. Psychiatric Services. 1996;47:871-873.

42 Kasper S, Schindler S, Neumeister A. Risk of suicide in depression and its implication for psychopharmacological treatment. International Journal of Psychopharmacology. 1996;11(2):71-79.

43 Owens D, Horrocks J, House A. Fatal and non-fatal repetition of self-harm. British Journal of Psychiatry. 2002;181:193-199.

44 Suokas J, Suominen K, Isometsa E, et al. Long-term risk factors for suicide mortality after attempted suicide – findings of a 14-year follow-up study. Acta Psychiatrica Scandinavia. 2001;104:117-121.

45 De Moore GM, Robertson AR. Suicide in the 18 years after deliberate self harm. British Journal of Psychiatry. 1996;169:489-494.

46 Gibb SJ, Beautrais AL, Fergusson DM. Mortality and further suicidal behaviour after an index suicide attempt: a 10-year study. Australian and New Zealand Journal of Psychiatry. 2005;39:95-100.

47 Kurz A, Moller HJ. Attempted suicide: efficacy of treatment programs. Psychiatry and Clinical Neurosciences. 1995;49:S99-S103.

48 McNeil DE, Binder RL. The impact of hospitalization on clinical assessments of suicide risk. Psychiatric Services. 1997;48:204-208.

49 Brent DA, Moritz G, Bridge J. Long-term impact of exposure to suicide: a three-year controlled follow-up. Journal of the American Academy of Child and Adolescent Psychiatry. 1996;35:646-653.

50 Sarfati Y, Bouchaud B, Hardy-Bayle M-C. Cathartic effect of suicide attempts not limited to depression: a short-term prospective study after deliberate self-poisoning. Crisis. 2003;24:73-78.

51 Matsuishi K, Kitamura N, Sato M, et al. Change of suicidal ideation induced by suicide attempt. Psychiatry and Clinical Neurosciences. 2005;59:599-604.

52 Hickey L, Hawton K, Fagg J, et al. Deliberate self-harm patients who leave the accident and emergency department without a psychiatric assessment: a neglected population at risk of suicide. Journal of Psychosomatic Research. 2001;50:87-93.

53 Kapur N, Cooper J, Hiroeh U. Emergency department management and outcome for self-poisoning: a cohort study. General Hospital Psychiatry. 2004;26:36-41.

54 Soderberg S, Kullgren G, Salander Renberg E. Childhood sexual abuse predicts poor outcome seven years after parasuicide. Social Psychiatry and Psychiatric Epidemiology. 2004;39:916-920.

55 Vajda J, Steinbeck K. Factors associated with repeat suicide attempts among adolescents. Australian and New Zealand Journal of Psychiatry. 2000;34:437-445.

56 Ostamo A, Lonnqvist J. Excess mortality of suicide attempters. Social Psychiatry and Psychiatric Epidemiology. 2001;36:29-35.

57 Cantor CH, Baume PJM. Access to methods of suicide: what impact? Australian and New Zealand Journal of Psychiatry. 1998;2:8-14.

58 Gunnell D, Frankel S. Prevention of suicide: aspirations and evidence. British Medical Journal. 1994;308:1227-1233.

59 Burns J, Dudley M, Hazel P. Clinical management of deliberate self-harm in young people: the need for evidence-based approaches to reduce repetition. Australian and New Zealand Journal of Psychiatry. 2005;39:121-128.

20.4 Depression

Introduction

The need to determine the presence and severity of a depressive syndrome is a very frequent task in the emergency department (ED). Assessment of depression is necessary in relation to a variety of patient presentations. The classic ED situation is the overdose, or other attempted suicide or self-harm, where the assessment of depression forms part of further evaluation after the patient has been medically stabilized. It is also becoming more common for patients to present to the ED complaining of depression (often on the advice of family, friends or crisis helplines) without having harmed themselves. Patients with a variety of medical conditions, especially conditions which are chronic or disabling, also often develop a depressive syndrome that can form a major part of the reason behind an ED attendance. Some patients who present to EDs with personal crisis or self-harm may have been identified as suffering from a personality disorder, but nevertheless need assessment for comorbid depression. The evaluation of depressive symptoms is also an important aspect of the assessment of patients seen in the ED with alcohol and drug abuse problems.

In these assessments it is very important to have a clear concept of the syndrome of ‘clinical depression’. This syndrome is called ‘depressive episode’ in The International Classification of Disease – 10th edition1 (ICD-10) and ‘major depression’ in the Diagnostic and Statistical Manual of Mental Disorders – 4th edition2 (DSM-IV). The importance of diagnosing a depressive episode lies principally in determining the presence of a clinical syndrome which is in need of treatment, is likely to respond to treatment and is likely to persist without treatment. The clear delineation of a depressive episode is also an essential basis for differential diagnosis from other medical and psychiatric conditions, and for distinguishing between the clinical syndrome of depression and the day-to-day fluctuations of mood and states of dejection, pessimism, frustration and disappointment which are the lot of all human beings.

The diagnosis of a depressive episode depends on the pervasive presence of a sufficient number of a specific list of symptoms. The list of symptoms contributing to the depressive episode syndrome in ICD-10 is shown in Table 20.4.1. The DSM-IV syndrome of major depression has the same list of symptoms, with the exception of ‘loss of confidence or self-esteem’. An adequate number of these symptoms must be present for at least 2 weeks before the diagnosis of depressive episode can be made. The pervasiveness of the symptoms is defined principally by the specifications that they must be present ‘most of the day’ and for ‘nearly every day’.

Table 20.4.1 Symptoms contributing to the diagnosis of a depressive episode in ICD-101

1. Depressed mood, most of the day, nearly every day, largely uninfluenced by circumstances
2. Markedly diminished interest or pleasure in all, or almost all, activities, most of the day, nearly all day
3. Loss of energy or fatigue, nearly every day
4. Loss of confidence or self-esteem
5. Unreasonable feelings of self-reproach, or excessive or inappropriate guilt, nearly every day
6. Recurrent thoughts of death or suicide, or any suicidal behaviour
7. Diminished ability to think or concentrate, or indecisiveness, nearly every day
8. Psychomotor agitation or retardation, nearly every day
9. Insomnia or hypersomnia, nearly every day
10. Change in appetite (decrease or increase with corresponding weight change)

ICD-10 further classifies depressive episodes into mild, moderate and severe, according to the total number of symptoms present (mild = 4/10 symptoms, moderate = 6/10 symptoms and severe = 8/10 symptoms). However, it is important to note that both the mild and moderate categories require the presence of at least two of the first three symptoms, that is the patient must have two of depressed mood, loss of interest or loss of energy, most of the day, nearly every day, for at least 2 weeks. The diagnosis of severe depressive episode requires the presence of all three of the first three symptoms.

The diagnosis of a depressive episode does not in any way depend on the presence or absence of a precipitating life event or situation. The ICD-10 also has a category of brief depressive reaction (one of the ‘adjustment disorders’), which forms part of the differential diagnosis of a depressive episode. This syndrome is defined by the presence of a precipitating life event and depressive symptoms. However, if the depressive symptoms are of sufficient number, pervasiveness and duration as to qualify for the description of a depressive episode, then this diagnosis should be made regardless of the presence of a precipitant. The notion that ‘this patient’s depression is understandable given the circumstances’ should never detract from a proper evaluation of the severity and duration of the symptoms.

It is an ICD-10 requirement that depressive syndromes which form part of a bipolar disorder, or are secondary to alcohol or other drug abuse or to a medical condition, should be given a different diagnostic category (‘bipolar affective episode, current episode mild, moderate or severe depression’, ‘mood disorder due to psychoactive substance use’ or ‘organic mood disorder’). The distinction is important because the treatment implications may be significant.

Prevention

Depression is a major public health problem. The World Health Organization has determined that in 1990 depression was the fourth leading cause of disease burden in the world and that by 2020 it would be the second leading cause of disease burden.12 Public health measures have included campaigns to raise awareness of depression both in the general public and in healthcare providers. ED staff can play a very significant role in case identification and in ensuring referral for effective treatment.

Clinical features

The syndrome described as a ‘depressive episode’ (or ‘major depression’) is defined principally by its symptoms and, to a lesser extent, signs. As the severity of the depressive episode is also dependent on specific characteristics of the individual symptoms and signs (as well as the total number of symptoms) it is also important to understand the varieties of their manifestations.

Symptoms

It is useful to start the history with an exploration of the problem which has brought the person to the ED. This problem may be an overdose or other attempted suicide or self-harm, a personal or relationship crisis, a period of alcohol or other drug abuse, an exacerbation of a chronic medical condition or chronic pain, or some other complaint. It is also important during the clinical assessment to begin to form some picture of who the patient is, including whether he or she lives alone or with others, the nature and quality of his or her personal relationships, and his or her daily occupation, interests and activities. These inquiries assist in building rapport through demonstrating an interest in the patient, but also elicit information that is necessary for understanding the patient’s symptoms in context.

At some point, the patient can be told that the interviewer would now like to explore the symptoms of depression in more detail. It may be helpful to group the symptoms of depressive episode (Table 20.4.1) into various domains of the patient’s experience. The first group (‘depressed mood’, ‘markedly diminished interest’, and ‘loss of energy’) refers to the pervasive mood state and the quality of the patient’s spirits or enthusiasm for life. The second group (‘loss of self-esteem’, ‘unreasonable self-reproach or guilt’, and ‘recurrent thoughts of death or suicide’) refers to the cognitive contents of the patient’s thoughts. The third group (‘diminished concentration’ and ‘psychomotor agitation or retardation’) refers to the degree of agitation or lethargy associated with the patient’s thought processes and physical activity. The final group (‘insomnia or hypersomnia’ and ‘change in appetite’) refers to physiological changes.

Both the pervasiveness and duration of these symptoms should be assessed. Pervasiveness is important because most of the symptoms can only be rated as present for the specific diagnosis of a depressive episode if they are present ‘nearly every day’. The syndrome is, by definition, one in which the symptoms have become persistent and inescapable, not the occasional or sporadic experience of these symptoms which nearly everybody endures sometimes. Duration is important because the syndrome must be present for at least 2 weeks before the diagnosis can be made.

The timing of onset of a depressive episode can be difficult to establish because the onset is often very gradual and insidious (although it can be relatively rapid). The patient may have experienced previous episodes which become confused with the present one, and patients often confuse long-term feelings of low self-esteem with the current episode. Hence the question ‘How long have you been feeling like this?’ is often unproductive. It is more useful to ask the patient to describe the presence and pervasiveness of each of the symptoms ‘during the last 2 or 3 weeks or so’ and in particular to try to identify some recent time at which there has been a change in the clinical state or function of the patient.

The pervasiveness and duration criteria taken together imply a diminished ability to carry out normal activities and meet responsibilities. Although many depressed patients push themselves to keep going, careful enquiry reveals that this has become more arduous. Difficulty in attending to tasks may range from diminished effectiveness at work, child care or study to, eventually, neglect of self-care and nutrition. Thus impairment in function is another indicator of the severity of the episode.

‘Depressed mood, most of the day, nearly every day’ is perhaps the most difficult of the symptoms to characterize. ‘Mood’ refers to a person’s underlying emotional state, the emotional baseline that permeates each day. It is useful to ask not only ‘Do you feel depressed?’ but also ‘What is that like for you?’. Some patients describe feeling much more unhappy than usual or sad all the time or unexpectedly tearful; others report feeling more irritable with others or more inclined to worry. The severity of the mood change may be shown in a loss of mood reactivity, which can be elicited by asking ‘Can you cheer yourself up, take your mind off your worries?’ and ‘Do you find that the things which normally make you happy don’t seem to cheer you up as much as usual?’.

‘Markedly diminished interest or pleasure in all, or almost all, activities, most of the day, nearly every day’ is somewhat easier to assess, especially if the interviewer takes the time to build up a picture of the patient’s usual day. With careful inquiry a nuanced picture can be built up of the extent of the patient’s withdrawal from his or her usual activities. Included within this criterion is a lack of pleasure or interest in sexual activity, which in more severe cases can be experienced as a profound loss of sexual feelings.

‘Loss of energy or fatigue, nearly every day’ is an important symptom which is sometimes overlooked. The emphasis should be on the loss of energy, that is whether the patient is aware of having much less energy or drive than usual. In severe cases, the patient may describe feeling the body is heavy or thoughts sluggish, at which point this symptom overlaps with ‘psychomotor retardation’. Loss of energy is an important symptom in differential diagnosis, which may point to such conditions as anaemia, hypothyroidism, diabetes or other undiagnosed medical condition.

The diagnosis of depressive episode requires the enduring presence of at least two of these mood-related symptoms, that is depressed mood, diminished interest and loss of energy. The most important part of the assessment is therefore the systematic exploration of these three symptoms.

The cognitive symptoms of depression (‘loss of self-esteem’, ‘unreasonable self-reproach or guilt’ and ‘recurrent thoughts of death or suicide’) can to some extent be observed in listening to the patient’s spontaneous comments, and as such form a part of the mental state examination. However, patients who are more introspective have some awareness of a change in thought processes and are able to describe the ways in which their thoughts have become more gloomy than usual. This insight is lost when depression becomes more severe and the patient tends to regard the self-reproach or thoughts of suicide as entirely justified.

In assessing ‘loss of confidence or self-esteem’, the emphasis should be on the loss or change in the person’s self-concept. It can be helpful to approach the issue with suggestive questions, such as ‘Tell me about a time when you felt better about yourself’, ‘Did you used to feel more confident at work?’ or ‘Was there a time when you felt more adequate as a parent?’.

‘Unreasonable feelings of self-reproach, or excessive or inappropriate guilt, nearly every day’ is probably one of the most consistently reliable symptoms pointing to a diagnosis of depressive episode. Sometimes a very conscientious person may habitually find fault with him- or herself without being clinically depressed. However, a person who is not depressed will usually be able to consider other points of view, to debate the sense of culpability internally and to consider whether the sense of guilt may be ‘excessive’, ‘inappropriate’ or ‘unreasonable’. This capacity to rationalize about thought processes becomes progressively more impaired as the patient becomes more severely depressed, until the patient’s guilt appears unquestionable.

In psychotic forms of depression the sense of guilt may take on bizarre dimensions in which the patient can feel responsible for all the evil in the world or for distant events. A not uncommon experience is for the patient to see a report on the television of a calamity such as an earthquake and to feel responsible for the event.

‘Recurrent thoughts of death or suicide’ can arise in a depressive episode in a variety of ways. Not uncommonly, the thoughts may simply come in to the patient’s mind: the patient reports having thoughts of being dead, wanting to be dead or thoughts of suicide that are uncharacteristic, unbidden and apparently inexplicable. Sometimes the suicidal thoughts are directly linked to excessive or delusional guilt, in which the patient feels his or her death to be necessary and inevitable: here the risk of suicidal action is very high.

In other cases, the suicidal thoughts are a logical consequence of a sense of hopelessness, a lack of faith in the future. This last type of suicidal ideation is less specific for the diagnosis of depressive episode, as it may also reflect an apparently realistic appraisal of life circumstances, an attitude of philosophical pessimism or poor coping skills in a person with impaired personality function. These distinctions are important because the suicidal ideation which is a part of a depressive episode may be expected to resolve with treatment of the depression, whereas the other forms may not.

‘Diminished ability to think or concentrate, or indecisiveness, nearly every day’ is a relatively straightforward symptom to assess and is useful as an indicator of the severity of the depressive episode. It can be assessed by asking about ability to focus on work or a recreational activity such as watching television or reading a book. Some patients report that their mind is easily distracted or restlessly inattentive. Many report the intrusion of negative ruminations (concerning lack of worth, sense of failure or guilt, thoughts of suicide or other worries) which go round and round in their minds. Progressive impairment in the capacity to concentrate will demonstrate increasing severity of depression: a severely depressed patient may not even be able to focus on one newspaper story and take in the contents.

‘Psychomotor agitation or retardation, nearly every day’ refers to abnormalities of movement, facial expression, speech and thought processes which are directly assessed in the mental state examination and are discussed more fully below. However, this can also to some extent be assessed through the history from the family. ‘Psychomotor agitation’ includes restless, fidgety behaviour, inability to sit still or attend to a task, and anxious, repetitive speech or even perseveration. ‘Psychomotor retardation’ includes lack of spontaneous bodily movement, lack of facial expression, lack of verbal communication and slowness of response. Retardation is the more common, and the patient or family may report progressive withdrawal and decrease in activity to the point where the patient sits for long hours apparently doing nothing. The presence of significant psychomotor agitation or retardation is usually indicative of a severe depressive episode.

Changes in sleep pattern (‘insomnia or hypersomnia, nearly every day’) are very common in depression, even in mild episodes. It is worth enquiring in detail about the specific changes in sleep pattern, as these relate to the severity of the depressive episode. Initial insomnia, or delay in the onset of sleep, is not specifically associated with depression, as it can be strongly associated with anxiety or primary insomnia. Middle insomnia (waking after 2 or 3 h of sleep) and early morning waking are more specific to depression. The extent of difficulty the patient has in going back to sleep, and the mood and thought content when awake during the night are also relevant.

Change in appetite may involve an increase or decrease with corresponding weight change. Severe loss of appetite with marked loss of weight, in the absence of medical illness or deliberate dieting, is associated with severe depression.

Signs

The most important signs are:

The patient with psychomotor agitation demonstrates, in milder forms, fidgety or repetitive behaviours such as hand wringing or sighing. This can progress to an inability to sit still and, eventually, continuous pacing. The patient may say little while looking very apprehensive and preoccupied, or may importune all the staff with repetitive, anxious questions, apparently seeking reassurance which is never achieved. In severe cases, speech becomes perseverative.

By contrast, the psychomotor-retarded patient maintains a relative immobility, lying in bed or sitting in a chair for long periods, with infrequent changes in posture. The face may be relatively expressionless, look sad or show an anxious dread. Both the facial expression and the body language show diminished reactivity during interview. There is little spontaneous speech and, if responses to questions can be elicited, the responses lack richness, depth or elaboration. Slowness of thought processes is shown especially by a marked increase (sometimes as long as several minutes) in the time taken to supply an answer to a question. In severe cases the patient may be mute.

The affective state of the depressed patient during the interview is most often sad, but sometimes anxious or even hostile. As the depression becomes more severe, the patient tends to show a diminished range of affects and have an impaired affective reactivity (for example, the patient does not smile in response to social cues).

During the interview it is important to observe the themes evident in the patient’s spontaneous conversation. Themes of despair, failure, guilt and death are typical of a depressive episode. The degree of insight may be a marker of the severity of the depressive episode.

Variants

Melancholic (somatic) depression

Some severe depressive episodes can be distinguished which have severe mood symptoms, marked changes in physiological function and significant psychomotor agitation or retardation.

This form of the depressive syndrome is designated ‘major depression with melancholia’ in DSM-IV and ‘depressive episode with somatic syndrome’ in ICD-10. The ICD-10 criteria for the ‘somatic syndrome’ are shown in Table 20.4.2. At least four of the eight symptoms must be present to make the diagnosis. Most ‘depressive episodes with somatic syndrome’ are also likely to meet the criteria for ‘severe depressive episode’.

Table 20.4.2 ICD-10 criteria for the ‘somatic syndrome’ (melancholia)1

1. Marked loss of interest in activities that are normally pleasurable
2. Lack of emotional reactions to events or activities that normally produce an emotional response
3. Waking in the morning 2 h or more before the usual time
4. Depression worse in the morning
5. Objective evidence of marked psychomotor retardation or agitation
6. Marked loss of appetite
7. Marked loss of libido

The clinical significance of making the diagnosis of melancholic depression is that this form of depression is likely to require intensive biological treatment.

Most of the symptoms contributing to the diagnosis of the ‘somatic syndrome’ are more severe and more specific forms of the symptoms of a ‘depressive episode’. It is not just any sleep disturbance, but marked early morning waking which is important. Similarly, it is not just a change in appetite, but a significant loss of weight which is important. The presence and severity of the psychomotor agitation or retardation is the most important sign, since these phenomena can be objectively and systematically observed and rated.13

Psychotic depression

This is discussed in Chapter 20.5. The patient with a psychotic depression will usually meet the criteria for a severe depressive episode, often with the ‘somatic syndrome’.

Mild and moderate depressive episodes

In clinical practice it is usually not difficult to recognize a ‘severe’ depressive episode, as the patient manifests eight out of 10 specified symptoms, including all three of the first three symptoms, and these symptoms must have been persistently present (‘nearly every day’) for at least 2 weeks.

Greater uncertainty may be associated with making the diagnosis of ‘mild’ or ‘moderate’ depressive episode, especially in patients who have a long-term history of poor self-esteem, or are temperamentally inclined to worrying, moodiness or irritability. Some research evidence14 suggests that these temperamental factors can affect the presentation of the depressive syndrome. Thus a person who is a habitual worrier who develops a depressive episode is likely to worry more, and perhaps to withdraw from social contact, or abuse alcohol or anxiolytic drugs. A person who tends to be moody or irritable is likely to become more so in a depressive episode, and may appear demanding, complaining and unreasonable.

Nevertheless the essential and salient characteristic of even a mild or moderate depressive episode is that the patient has a persistent mood change, manifested by at least two of persistent depressed mood, persistent loss of interest and persistent loss of energy, which have been present for at least 2 weeks. These are the symptoms which the interviewer needs to explore in greatest detail because it is their enduring presence which makes the diagnosis clear. Of the additional symptoms contributing to the diagnosis of depressive episode, probably the most common are difficulty with sleep and diminished ability to think and concentrate.

A patient with persistent depressed mood and impaired concentration almost certainly has some functional impairment. A useful approach to this question is to ask the patient about normal daily activities and then assess the extent to which these activities are disrupted by the symptoms. Can the patient do household chores? Does this require unusual effort? Can the patient go to work? Is the patient functional at work? Are even simple leisure activities like watching television disrupted by the patient’s mood state? It is this evidence of change in function which permits the identification of a mild or moderate depressive episode, regardless of pre-existing temperamental vulnerabilities.

Depression in the elderly

The symptoms of depression in older people are generally very similar to those in younger age groups and should be assessed in a similar way.15 Symptoms such as loss of energy, insomnia or change in appetite may also be influenced by comorbid medical illness, but a persistent mood change or loss of interest should prompt consideration of a depressive episode. Older people may tend to minimize their feelings of depression and in these cases a collateral history of loss of interest in usual activities may be found. Not uncommonly older people are seen in the ED following an overdose that may appear medically trivial. These patients should always be carefully assessed for the presence of a depressive syndrome.

‘Pseudo-dementia’ is a term used to describe patients with a depressive syndrome who present with an apparent change in cognitive function. The patient with depressive pseudo-dementia is likely to have a relatively recent and relatively abrupt change in concentration and memory. In contrast to the patient with dementia, the patient with pseudo-dementia usually shows a great awareness of having memory difficulties and will tend to demonstrate the impairment to the interviewer with considerable anxiety. In addition, the patient with depressive pseudo-dementia manifests other symptoms of a depressive episode.

Differential diagnosis

The differential diagnosis of the depressive syndrome is important because there are several other clinical disorders involving depressed mood or other symptoms of depression which have a different prognosis and treatment.

Bipolar depression

ICD-10 specifies that in a person who has a history of bipolar disorder, a diagnosis of ‘depressive episode’ should not be made even if the patient meets the criteria for a depressive episode. Instead the diagnosis of ‘bipolar affective episode, current episode mild, moderate or severe depression’ should be made. The distinction is important because of the treatment and prognosis. In particular, antidepressant medication should be used very cautiously in the person with bipolar disorder because of the risk of provoking a switch to mania.

The symptoms of a bipolar depressive episode are in themselves not different from the symptoms of any other episode of depression. The distinction therefore rests on a previous history of treatment for bipolar disorder or a history of a manic episode that may not have been treated.

A manic episode, as defined in ICD-10,1 involves an elevated or irritable mood sustained for at least a week, and at least three (or at least four if the mood is only irritable) of the signs shown in Table 20.4.3. Mania is discussed in more detail in Chapter 20.5.

Table 20.4.3 Signs contributing to the diagnosis of a manic episode in ICD-101

1. Increased activity or physical restlessness
2. Increased talkativeness (‘pressure of speech’)
3. Flight of ideas or subjective experience of thoughts racing
4. Loss of normal inhibitions, resulting in behaviour that is inappropriate to the circumstances
5. Decreased need for sleep
6. Inflated self-esteem or grandiosity
7. Distractibility or constantly changing activity or plans
8. Behaviour that is foolhardy or reckless
9. Marked sexual energy or sexual indiscretions

The depressed patient seen in ED who is suspected of having a bipolar disorder should usually be referred to a psychiatrist for assessment and treatment. Bipolar disorder is a life-long condition, with a high rate of recurrent episodes, which requires specialized pharmacological and psychological management.

Organic mood disorder

Many medical conditions (Table 20.4.4) are especially associated with a typical depressive syndrome. Because the medical condition is considered likely to have a pathophysiological significance in the development of the depressive syndrome, these conditions are termed ‘organic mood disorders’.

Table 20.4.4 Medical conditions associated with depressive syndrome

Hyperthyroidism
Hypercalcaemia
Pernicious anaemia
Pancreatic cancer
Lung cancer
Stroke
Alzheimer’s dementia
Vascular dementia
Parkinson’s disease
Huntington’s disease
AIDS
Central nervous system tumour
Multiple sclerosis
Neurosyphillis
Brucellosis

Occasionally the depressive syndrome may be the first presentation of a previously undiagnosed medical illness. Clinical or laboratory evidence of hypothyroidism was found in 5% of patients with a depressive syndrome in one series.17 Hypercalcaemia due to unsuspected hyperparathyroidism very occasionally presents with depressed mood, lethargy or cognitive change as the presenting symptoms.18 The first presentation of pancreatic cancer with a depressive syndrome is well recognized.19 A depressive syndrome may be the first presentation of Huntington’s disease, before the onset of the movement disorder, and the diagnosis will only be suggested by the family history.20 Some patients with HIV infection have been found to present with a mood disorder before manifesting other symptoms of AIDS.21 Because many medical conditions associated with depressive symptoms involve central nervous system disease, any neurological signs should prompt investigation for, for example, unsuspected cerebral tumour.

However, more commonly the depressive syndrome presents in a patient with an already recognized medical illness. In these cases it is important to evaluate carefully the severity and persistence of the depressive symptoms and not dismiss them as an understandable reaction to the illness. Symptoms such as loss of energy, sleep disturbance and anorexia may be difficult to evaluate, as they may be related to other pathophysiological change, but the patient with persistent depressed mood, loss of pleasure in activities, marked loss of self-esteem and feelings of guilt or hopelessness is likely to be experiencing a depressive episode. If such a depressive episode is diagnosed and treated, the patient will experience relief of suffering and a greater ability to deal effectively with other medical problems.

Many drugs have been associated with depressive symptoms, often based on only a few case reports.22 Medications with a particularly strong association with depression include interferon, isotretinoin, methyldopa, benzodiazepines, digitalis, β-blockers, oral contraceptives and corticosteroids. A useful approach is to consider drugs which have recently been introduced in relation to the time course of the depressive symptoms.

Mood disorder due to psychoactive substance use

Chronic alcohol misuse is frequently associated with depressed mood, low self-esteem and feelings of guilt and hopelessness. Severe sleep disturbance can also be precipitated by rebound wakefulness as blood alcohol levels fall during the night. The person who regularly abuses alcohol is also likely to experience fatigue, impaired concentration, appetite disturbance and loss of sex drive. These symptoms may mimic those due to a depressive episode, such that it is not possible to make a differential diagnosis of a depressive episode while the patient continues to drink, nor is it likely that the depressive symptoms will remit without abstinence. Patients with alcohol-induced mood disorders should be encouraged to attend alcohol detoxification and rehabilitation programmes. There is some evidence that anti-depressant medication may help to reduce both depressive symptoms and alcohol consumption.23

Amphetamine withdrawal is often associated with a markedly depressed mood, which usually improves within a few days if the patient remains abstinent.

The abuse of alcohol and other drugs is sometimes an attempt to self-medicate for a pre-existing depressive syndrome. This history should be especially sought in the patient whose abuse of alcohol or other drugs is of recent onset or follows important life-change such as bereavement or divorce. Even if a pre-existing depressive syndrome is identified, however, the patient should be informed that abstinence is necessary for recovery.

Personality disorder

The concept of personality disorder refers to enduring patterns of behaviour, including especially interpersonal behaviours, which are well outside the usually sanctioned range of behaviours in a particular culture and which are associated with substantial subjective distress or conflict with others. The diagnosis of personality disorder should only be made if the behaviour patterns are persistent, relatively inflexible and have been present since a young age, often beginning in childhood or adolescence.

Although a variety of specific personality disorders have been described, the two most common forms in the ED are antisocial personality disorder and borderline personality disorder.

Persons with antisocial personality have a long-term history of disregard for social rules, usually resulting in a chequered employment history, broken relationships and often violent or criminal behaviour. As a result of personal crisis precipitated by these behaviours, persons with antisocial personality not infrequently present to ED with acute brief depressive reactions, helplessness and suicidal ideation or behaviour. Assessment should be especially directed at clarifying if a superimposed persistent depressive episode is present and the severity of this episode. Inpatient psychiatric treatment is problematic because the patient often has difficulty adhering to ward rules and expectations.

If the depressive symptoms are not severe and seem to be reactive to recent stressors, it is preferable to try to engage the patient in a realistic discussion of the current problems and, if possible, make a referral to crisis counselling. In some cases, however, when the depressive symptoms are more severe and the risk of suicidal behaviour is high, it may be necessary to arrange inpatient admission.

The person with borderline personality disorder displays persistent severely immature interpersonal behaviour, as well as considerable impulsivity and recklessness. The interpersonal behaviours include a strong tendency to see others in ‘all good’ or ‘all bad’ terms, and to blame others for the patient’s own feelings and behaviours. Reckless and impulsive behaviours include abrupt breaches in relationships, alcohol and other drug abuse, and self-damaging acts such as cutting. Persons with borderline personality often describe chronic feelings of emptiness and loneliness, often associated with suicidal ideation. These features are sometimes misdiagnosed as depression when they may actually represent the patient’s usual way of feeling rather than a discrete depressive episode. Because borderline personality disorder is a long-term condition, intervention with the patient who presents in the ED in crisis should if possible be directed towards facilitating or enhancing the patient’s engagement with outpatient treatment services.

As many as 50% of patients with borderline personality may also meet the criteria for a depressive episode at any one time.27 Although a diagnosis of borderline personality may have been made on the basis of the longitudinal history, it is therefore also important to try to assess the severity, persistence and duration of current depressive symptoms. If the patient is already engaged with an outpatient mental health clinician, it is useful to liaise with the therapist regarding recent symptoms and function.

Assessment

The assessment of the patient for depression should cover:

It is generally a good idea to start the interview with some basic social information. Does the patient live alone? How is he or she occupied or employed? Is there a supportive relationship or other family? This information assists in understanding the context of the symptoms and helps with treatment planning.

Exploration of precipitating events is important partly because these worries are likely to be occupying the mind of the patient and discussion of these issues helps to build rapport in the interview.

Identification of the presence and severity of the depressive symptoms is the most important part of the assessment. Unfortunately, it is often not done systematically and the ‘diagnosis’ of depression is made only on the basis of a patient’s statement about ‘being depressed’ and one or two other symptoms such as sleep and appetite disturbance. Systematic evaluation requires detailed exploration of the symptoms described above. Particular attention should be paid to the persistence, pervasiveness and duration of the symptoms. If this systematic approach is taken it is possible to determine:

The proper diagnosis of a depressive syndrome and the assessment of the severity of the syndrome are of major importance in treatment planning.

There may be insufficient time in an emergency interview to explore fully the previous psychiatric history. However, it is useful to ask if the patient has been depressed before, whether or not any previous episodes were treated and what was the response to previous treatment. It is also important to identify any previous episodes of mania in case the depressive episode may be a presentation of bipolar disorder.

Mental state examination focuses on the signs described above. Persistently sad affect and noticeable psychomotor agitation or retardation are indicators of more severe depression. Similarly, if the patient’s conversation is very preoccupied with themes of failure, despair, guilt or death the depression is likely to be more severe. Inquiry about these matters should be extended to look for delusional beliefs. Useful questions may include ‘Do you feel responsible for bad things happening?’, ‘Do you feel there is something drastically wrong with you?’ or ‘Do you believe you deserve punishment?’. Understanding the patient’s level of insight into his or her condition is also important to treatment planning, particularly if involuntary treatment should become necessary due to the risk of suicide.

Risk assessment is multi-faceted. If the patient has attempted suicide through overdose or other means, inquiry should be made about the circumstances of this attempt, the patient’s understanding of the lethality of the attempt and whether or not the patient sought help afterwards or made an effort to conceal the attempt. The patient’s current thoughts about suicide and his or her attitude to suicide are also relevant. Many patients admit to having thoughts of suicide but indicate that they would be deterred from suicidal action by, for example, having responsibility for dependent children. The disappearance of these ‘protective factors’ from a patient’s considerations is an indicator of worsening risk. Patients with psychotic depression may be at higher risk because they lack such ‘emotional’ constraints on suicidal behaviour. Other factors associated with increased suicide risk include lack of supportive relationship, living alone, being unemployed and current alcohol abuse.

A primary medical condition causing depressive symptoms is likely to be suggested by other symptoms and signs, or be pre-existing. There are no mandatory investigations for the assessment of a depressive episode, although checking thyroid biochemistry is sensible.

Inquiry should be made about alcohol and other drug-use patterns, and especially recent changes in pattern use. A person with long-standing alcohol or other drug abuse is likely to have a substance-induced mood disorder, and needs to address this as the major focus of treatment. A recent marked increase in alcohol or other drug use may indicate an attempt to self-medicate for a depressive syndrome.

It is always useful to ask the patient if she or he is currently seeing a psychiatrist, psychologist or other mental health therapist, or has a good relationship with a trusted GP. These existing healthcare professionals can often be the natural starting point in planning treatment interventions.

Treatment

Treatment for a depressive episode involves the prescription of specific antidepressant medication or a specific course of psychotherapy or both.

Medications

Commonly used first-line antidepressant medications are shown in Table 20.4.5. Because no one of these medications has been shown consistently to have superior efficacy, choice of medication is based on the acceptability of the side effect profile and previous treatment response.

The selective serotonin re-uptake inhibitors (SSRIs) are usually well tolerated and are a good first choice. Some patients experience agitation, nausea or gastrointestinal hypermotility when they start SSRI medications. These symptoms usually settle in a week or two. The most troublesome long-term side effect of SSRIs is sexual dysfunction (especially delayed ejaculation or anorgasmia). These side effects sometimes require a change of medication. The side effects of venlafaxine are similar to SSRIs, with the addition of excessive sweating and itch at high doses.

Mirtazapine has useful sedating properties and can be very helpful in a patient with marked insomnia or agitation. Because it stimulates appetite, its use is limited in patients with a weight problem. Mirtazapine, reboxitine and moclobemide are useful alternatives for patients who experience sexual dysfunction with SSRIs or venlafaxine.

Tricyclic antidepressants (e.g. imipramine, amitriptyline and dothiepin) and irreversible monoamine oxidase inhibitors (MAOIs; phenelzine and tranylcypromine) continue to be prescribed for some patients, but they tend not to be first-line drugs. The use of tricyclics has decreased because of side effects (especially anticholinergic) and because of their cardiac toxicity in overdose. Irreversible MAOIs are generally inconvenient to take because of the need for dietary restrictions.

Evidence

All currently available antidepressants have been shown to achieve better symptom reduction than placebo, with no one antidepressant consistently demonstrating superior efficacy.30 In drug trials, up to 40% of patients in the placebo arm show improvement, which may include the non-specific effects of supportive interventions, as well as spontaneous remissions.31 As the natural history of depression in a community sample (which includes relatively minor, untreated cases) shows a median episode duration of 12 weeks, spontaneous remission appears to be not uncommon.32 Patients with psychotic depression respond better to the combination of an antidepressant and an antipsychotic medication than to an antidepressant medication alone.33

Both CBT and IPT have been shown to be effective in achieving symptom reduction compared to pill placebo control.34,35 CBT and IPT have been shown to be as effective as medication for mild-to-moderate depression.35 For a severe depressive episode, psychotherapy alone is not as effective as medication alone or a medication-psychotherapy combination.36

There are no systematic data regarding supportive psychotherapy (as it is not a standardized treatment) but substantial clinical experience attests to its efficacy.

References

1 World Health Organization. The ICD-10 classification of mental and behavioural disorders. Geneva: WHO, 1993.

.

2 American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington DC: American Psychiatric Association, 1994.

3 Joyce P. Epidemiology of mood disorders. In: Gelder M, Lopez-Ibor J, Andreasen N, editors. New Oxford textbook of psychiatry. Oxford: Oxford University Press; 2000:695-701.

4 Judd J. The clinical course of unipolar major depressive disorders. Archives of General Psychiatry. 1997;54:989-991.

5 Katz M, Secunda S, Hirschfeld R, et al. NIMH clinical research branch collaborative program on the psychobiology of depression. Archives of General Psychiatry. 1979;36:765-771.

6 Cross National Collaborative Group. The changing rate of major depression. Cross national comparisons. Journal of American Medical Association. 1992;268:3098-3105.

7 Tennant C. Life events, stress and depression: a review of recent findings. Australian and New Zealand Journal of Psychiatry. 2002;36:173-182.

8 Frank E, Anderson B, Reynolds C. Life events and research diagnostic criteria endogenous subtype. Archives of General Psychiatry. 1994;51:519-524.

9 Kendler K, Thornton L, Gardner C. Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the ‘kindling’ hypothesis. American Journal of Psychiatry. 2000;157:1243-1251.

10 Schildkraut J. The catecholamine hypothesis of affective disorders: a review of supporting evidence. American Journal of Psychiatry. 1965;122:509-522.

11 Jacobs B, Praag H, Gage F. Adult brain neurogenesis and psychiatry: a novel theory of depression. Molecular Psychiatry. 2000;5:262-269.

12 Murray C, Lopez A. The global burden of disease and global health statistics. Boston: Harvard University Press, 1996.

13 Parker G, Hadzi-Pavlovic D. Melancholia: a disorder of movement and mood. Cambridge: Cambridge University Press, 1996.

14 Parker G, Hadzi-Pavlovic D, Roussos J, et al. Non-melancholic depression: the contribution of personality, anxiety and life-events to subclassification. Psychological Medicine. 1998;28:1209-1219.

15 Musetti L, Perugi G, Soriani A, et al. Depression before and after age 65: a re-examination. British Journal of Psychiatry. 1989;155:330-336.

16 Lindemann E. The symptomatology and management of acute grief. American Journal of Psychiatry. 1944;101:141.

17 Gold M, Pottash A, Extein I. Hypothyroidism and depression. Journal of the American Medical Association. 1981;245:1919-1922.

18 Watson L. Clinical aspects of hyperparathyroidism. Proceedings of the Royal Society of Medicine. 1968;61:1123.

19 Joffe R, Rubinow D, Denicoff K, et al. Depression and carcinoma of the pancreas. General Hospital of Psychiatry. 1986;8:241-245.

20 Folstein S, Abbott M, Chase G, et al. The association of affective disorder with Huntington’s disease in a case series and in families. Psychological Medicine. 1983;13:537-542.

21 Atkinson J, Grant I, Kennedy C, et al. Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. Archives of General Psychiatry. 1988;45:859-864.

22 Hales R, Yudofsky S. The American psychiatric publishing textbook of clinical psychiatry, 4th edn, Washington: American Psychiatric Publishing; 2003:462-463.

23 Cornelius J, Salloun I, Ehler J, et al. Fluoxetine reduced depressive symptoms and alcohol consumption in patients with co-morbid major depression and alcohol dependence. Archives of General Psychiatry. 1997;54:700-705.

24 Akiskal H, Cassano G, editors. Dysthymia and the spectrum of chronic depressions. New York: Guildford Press, 1997.

25 Waintraub L, Guelfi J. Nosological validity of dysthymia. Part 1, historical, epidemiological and clinical data. Europeon Psychiatry. 1998;13:173-180.

26 Haykal R, Akiskal H. The long-term outcome of dysthymia in private practice. Clinical features, temperament and the art of management. Journal of Clinical Psychiatry. 1999;60:508-518.

27 Gunderson J. Borderline personality disorder: a clinical guide. Washington: American Psychiatric Publishing, 2001.

28 Seligman M. Learned optimism. New York: Random House, 1991.

29 Weissman M, Markowitz J, Klerman G. Comprehensive guide to interpersonal psychotherapy. New York: Basic Books, 2000.

30 Nemeroff C, Schatzberg A. Pharmacological treatment of unipolar depression. In: Nathan P, Gorman J, editors. A guide to treatments that work. New York: Oxford University Press; 1998:212-215.

31 Paykel E, Scott J. Treatment of mood disorders. In: Gelder M, Lopez-Ibor J, editors. New Oxford textbook of psychiatry. Oxford: Oxford University Press; 2000:724-736.

32 Eaton W, Anthony J, Gallo G, et al. Natural history of diagnostic interview schedule/DSM-IV major depression: the Baltimore epidemiologic catchment area follow-up. Archives of General Psychiatry. 1997;54:993-999.

33 Schatzberg A, Rothschild A. Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV? American Journal of Psychiatry. 1992;149:733-745.

34 Dobson K. A meta-analysis of the efficacy of cognitive therapy for depression. Journal of Consulting and Clinical Psychology. 1988;57:414-419.

35 Elkin I, Shea M, Watkins J, et al. National Institute of Mental Health treatment of depression collaborative treatment programme. Archives of General Psychiatry. 1992;46:971-982.

36 Thase M, Greenhouse J, Frank E, et al. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Archives of General Psychiatry. 1997;54:1009-1015.